What is CoVigilAI?
CoVigilAI represents a state-of-the-art innovation in the realm of medical literature monitoring, harnessing the power of artificial intelligence and advanced data analytics to proactively detect and manage adverse drug reactions, ensuring patient safety and compliance with regulatory requirements in real-time. This platform facilitates the efficient tracking of scientific and medical literature by retrieving data from prominent global databases such as PubMed and Embase, and it offers customizable search options that improve the pharmacovigilance literature review process. Furthermore, it conducts thorough evaluations of scientific articles and publications from various regional journals, guaranteeing an extensive oversight of both global and localized literature. With the implementation of sophisticated algorithms, the system categorizes Individual Case Safety Reports (ICSRs) into three distinct classifications: valid, potential, and invalid cases, while its automated key entity recognition feature proficiently pinpoints critical components such as patients, medications, adverse reactions, and pertinent medical events. This comprehensive strategy not only streamlines the monitoring procedure but also considerably boosts the precision and efficiency of drug safety evaluations, contributing to a safer healthcare environment. Ultimately, CoVigilAI serves as an indispensable tool for enhancing drug safety and fostering informed decision-making in the medical field.
Integrations
Similar Software to CoVigilAI
IQVIA
Across the globe, various organizations turn to IQVIA to expedite the drug development journey, ensuring product safety and quality while improving commercial effectiveness, facilitating appropriate treatment access for patients, and ultimately driving better health outcomes through enhanced healthcare delivery. By adopting a modern approach to clinical development that incorporates data, technology, and analytics, you can streamline your trials effectively. The result? Faster decision-making processes and reduced risks, allowing for the faster introduction of groundbreaking therapies. Leveraging its deep industry expertise, extensive data, and advanced analytics, IQVIA provides customized solutions to a diverse range of clients within the healthcare sector. You can keep up with the latest findings and updates shared by IQVIA's experts, including data scientists, healthcare professionals, and researchers, on significant topics that align with your interests. From trending industry shifts to practical applications of innovative capabilities, a treasure trove of knowledge is available for your exploration. Engaging with this rich content not only keeps you informed but also equips you to navigate successfully in an ever-changing healthcare landscape, ensuring you are always one step ahead.
Learn more
ScriptSure
ScriptSure Cloud ERX stands out as the leading e-prescribing solution on the market. It offers a range of features including weekly medication updates, daily pharmacy list refreshes, comprehensive network connectivity for e-prescribing, and the ability to electronically prescribe controlled substances (EPCS), all accessible through a user-friendly web interface. Additionally, it supports electronic refills, order sets, compounded medication orders, and provides tools for printing prescriptions, generating patient reports, and maintaining audit logs. Furthermore, ScriptSure ensures full compliance with HIPAA regulations. Over the years, ScriptSure Cloud ERX has garnered significant recognition, winning the Surescripts Network White Coat Award for Most Accurate Prescriptions in 2021, 2022, and 2023, totaling eleven awards in this esteemed category. This level of consistency in performance highlights the platform's commitment to excellence in e-prescribing services.
Learn more
Bibliovigilance
Bibliovigilance functions as a dedicated search engine specifically tailored for pharmacovigilance literature, aimed at improving the effectiveness of monitoring scientific and medical publications for insights related to safety. It features a comprehensive collection of significant national scientific publications from Europe and various other locations, covering both human and veterinary products. Users can perform global searches by querying PubMed and examining PRAC safety recommendations regarding signals, which allows for the integration of all literature searches into one convenient platform. Moreover, the tool provides users with the ability to save their search efforts and set up automatic updates, with filters available to display only new articles published since their last inquiry, thereby enhancing workflow efficiency and reducing repetitive searches. Each search is stored in a personal area, allowing users to easily revisit and assess their search history as needed. The database undergoes regular updates, guaranteeing that users have access to the most current information on publications, recent revision dates, and a precise tally of indexed articles, which enhances transparency and trustworthiness in the content offered. In addition, the platform's intuitive features promote regular usage, making it an essential asset for experts in the pharmacovigilance domain. As a result, Bibliovigilance not only supports professionals in their research endeavors but also contributes to the overall improvement of drug safety monitoring practices.
Learn more
Compier Literature Screening
Compier Literature Screening is an AI-driven tool designed to assist pharmacovigilance professionals in enhancing the efficiency of their review processes for abstracts, full texts, and translated documents to extract relevant details regarding patients, authors, events, products, and safety information. This cutting-edge platform integrates effortlessly with a range of online biomedical databases, such as Medline, and empowers users to upload large volumes of literature from diverse sources like Embase, conference proceedings, and PDF journals. It performs automated checks to eliminate duplicate entries for each literature search and utilizes validated AI technologies for the automatic identification and annotation of critical information. Users can customize scalable literature screening workflows tailored to their specific requirements while adhering to global regulatory standards. The system further fosters collaboration with external vendors to obtain full texts and is equipped with capabilities for translation. Additionally, it integrates seamlessly with safety management systems like Oracle Argus Safety, facilitating the sharing of articles pertinent to Individual Case Safety Reports (ICSRs) and thereby bolstering thorough safety monitoring. By streamlining these processes, the platform ultimately aims to enhance both the accuracy and effectiveness of pharmacovigilance operations, providing a valuable resource for professionals in the field. Furthermore, its user-friendly interface ensures that even those with minimal technical expertise can navigate the system efficiently.
Learn more
Screenshots and Video
Company Facts
Company Name:
CoVigilAI
Company Location:
India
Company Website:
covigilai.in/
Product Details
Deployment
SaaS
Training Options
Documentation Hub
Online Training
On-Site Training
Support
Standard Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English